Synthetic Biology
Conservative Site-specific Recombination and Phase Variation
Methods of Nuclear Reprogramming
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Aug 26, 2025

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics
Published on: September 22, 2011
James Donaldson1, Dirk-Jan Kleinjan1, Susan Rosser1
1UK Centre for Mammalian Synthetic Biology at the Institute of Quantitative Biology, Biochemistry, and Biotechnology, School of Biological Sciences, University of Edinburgh, Edinburgh, UK.
Dynamic engineering of Chinese hamster ovary (CHO) cells using synthetic biology offers a novel approach to biopharmaceutical production. These self-regulating cells can adapt to changing culture conditions, optimizing productivity throughout the fed-batch process.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: